| Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma F Iser, F Hinz, DC Hoffmann, N Grassl, C Güngoör, J Meyer, L Dörner, ... Clinical Cancer Research 30 (14), 2974-2985, 2024 | 3 | 2024 |
| CD70-specific CAR-T cell therapy for the treatment of glioblastoma A Kourtesakis, HNH Chow, DA Agardy, E Bailey, S Horschitz, A Jabali, ... Cancer Research 84 (6_Supplement), 55-55, 2024 | | 2024 |
| Reply to Pisan et al.: Pathogenicity of inherited TRAF7 mutations in congenital heart disease K Mishra-Gorur, T Barak, LD Kaulen, O Henegariu, SC Jin, SM Aguilera, ... Proceedings of the National Academy of Sciences 121 (12), e2319578121, 2024 | | 2024 |
| A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1 L Hai, DC Hoffmann, RJ Wagener, DD Azorin, D Hausmann, R Xie, ... Nature Communications 15 (1), 968, 2024 | 3 | 2024 |
| Neue Therapiestrategien beim primären Lymphom des Zentralnervensystems S Seidel, L Kaulen, L von Baumgarten Der Nervenarzt 95 (2), 117-124, 2024 | | 2024 |
| Suggested searches E Axell, J Hu, M Lindberg, AJ Dear, L Ortigosa-Pascual, EA Andrzejewska, ... Perspective, 2024 | | 2024 |
| A clinically applicable connectivity signature for glioblastoma includes the tumor network DD Azorin, D Hausmann, R Xie, MC Huppertz, J Hiblot, P Sievers, ... Nature Communications 15, 968, 2024 | | 2024 |
| Primary and Secondary CNS Lymphomas LD Kaulen, NA Blondin, FH Hochberg, JM Baehring Cancer Consult: Neoplastic Hematology & Cell Therapy 2, 563-578, 2023 | | 2023 |
| BIOM-64. A PROGNOSTIC SCORING SYSTEM FOR IMMUNODEFICIENCY-ASSOCIATED PRIMARY CNS LYMPHOMAS: AN INTERNATIONAL MULTI-CENTER STUDY P Karschnia, BL Traub, S Doubrovinskaia, B Richter, S Seidel, L Kuschel, ... Neuro-Oncology 25 (Supplement_5), v19-v19, 2023 | | 2023 |
| New treatment strategies for primary lymphoma of the central nervous system S Seidel, L Kaulen, L von Baumgarten Der Nervenarzt, 2023 | | 2023 |
| Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial T Kessler, D Schrimpf, L Doerner, L Hai, LD Kaulen, J Ito, M van den Bent, ... Clinical Cancer Research 29 (19), 3892-3900, 2023 | 5 | 2023 |
| Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus-(EBV) positive primary CNS lymphomas LD Kaulen, E Denisova, F Hinz, L Hai, D Friedel, O Henegariu, ... Acta neuropathologica 146 (3), 499-514, 2023 | 4 | 2023 |
| Pleiotropic role of TRAF7 in skull-base meningiomas and congenital heart disease K Mishra-Gorur, T Barak, LD Kaulen, O Henegariu, SC Jin, SM Aguilera, ... Proceedings of the National Academy of Sciences 120 (16), e2214997120, 2023 | 8 | 2023 |
| Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study S Doubrovinskaia, CM Mooshage, C Seliger, HM Lorenz, S Nagel, ... European journal of neurology 30 (2), 463-473, 2023 | 18 | 2023 |
| Treatment options for recurrent primary CNS Lymphoma LD Kaulen, JM Baehring Current treatment options in oncology 23 (11), 1548-1565, 2022 | 1 | 2022 |
| Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a follow-up study. S Doubrovinskaia, C Mooshage, C Seliger, HM Lorenz, S Nagel, ... European Journal of Neurology, 2022 | | 2022 |
| Metabolic heterogeneity of brain tumor cells of proneural and mesenchymal origin C Seliger, AL Meyer, V Leidgens, L Rauer, S Moeckel, B Jachnik, ... International journal of molecular sciences 23 (19), 11629, 2022 | 8 | 2022 |
| FACTORS EFFECTING EARLY DIAGNOSIS IN NEUROLYMPHOMATOSIS A Egert, P Karschnia, A Huttner, JM Baehring, LD Kaulen NEURO-ONCOLOGY 24, 2022 | | 2022 |
| P11. 46. A Whole exome sequencing identifies novel SLIT2 mutations in primary CNS lymphoma LD Kaulen, EZ Erson-Omay, O Henegariu, P Karschnia, A Huttner, ... Neuro-Oncology 24 (Suppl 2), ii68, 2022 | | 2022 |
| Clinical reasoning: a 64-year-old man with history of meningitis presenting with proximal weakness of the arms P Karschnia, L Kaulen, N Thon, JM Baehring Neurology 98 (5), 208-213, 2022 | 1 | 2022 |
